Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination

Abstract Gardasil® (Merck) and Cervarix® (GlaxoSmithKline) both provide protection against infection with Human Papillomavirus 16 (HPV16) and Human Papillomavirus 18 (HPV18), that account for around 70% of cervical cancers. Both vaccines have been shown to induce high levels of neutralizing antibodi...

Full description

Bibliographic Details
Published in:	npj Vaccines
Main Authors:	Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger, Galit Alter
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Online Access:	https://doi.org/10.1038/s41541-023-00628-8

Similar Items

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017-06-01)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.
by: Anna Godi, et al.
Published: (2015-01-01)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007-04-01)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007-04-01)

Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
by: Nitesh K. Kunda, et al.
Published: (2019-08-01)

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
by: Kathryn A. Bowman, et al.
Published: (2022-10-01)

Experience of realization of the pilot project on vaccination against HPV infection by Gardasil of girls in St.-Petersburg
by: S. M. Kharit, et al.
Published: (2014-09-01)

HPV Type 6 and 18 Coinfection in a Case of Adult-Onset Laryngeal Papillomatosis: Immunization with Gardasil
by: Virginia Fancello, et al.
Published: (2015-01-01)

A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand.
by: Suchada Jiamsiri, et al.
Published: (2022-01-01)

Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort
by: Alltalents T. Murahwa, et al.
Published: (2024-01-01)

Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
by: Victoria López-Codony, et al.
Published: (2024-01-01)

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
by: Elie Richel, et al.
Published: (2023-10-01)

Fc-engineered antibodies with immune effector functions completely abolished.
by: Ian Wilkinson, et al.
Published: (2021-01-01)

IgG Fc engineering to modulate antibody effector functions
by: Xinhua Wang, et al.
Published: (2017-10-01)

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
by: X. Tong, et al.
Published: (2023-07-01)

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
by: Julie M. Fox, et al.
Published: (2023-05-01)

Gardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children’s Hospital, Cape Town
by: Shavina Frank, et al.
Published: (2024-05-01)

Distinct effector functions mediated by Fc regions of bovine IgG subclasses and their interaction with Fc gamma receptors
by: Alistair Noble, et al.
Published: (2023-11-01)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
by: Yannic C. Bartsch, et al.
Published: (2023-05-01)

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound
by: Rasmus Offersen, et al.
Published: (2020-12-01)

Incident HPV 51 Infection after Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®
by: Philippe Halfon, et al.
Published: (2010-01-01)

Fc-Mediated Effector Functions of Anti-NS1 Antibodies in Dengue
by: Romchat Kraivong
Published: (2025-09-01)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
by: Bronwyn M. Gunn, et al.
Published: (2021-11-01)

Corrigendum: Gardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children’s Hospital, Cape Town
by: Shavina Frank, et al.
Published: (2024-07-01)

Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies
by: Erin Stefanutti, et al.
Published: (2025-09-01)

Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
by: Josée Golay, et al.
Published: (2022-06-01)

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
by: Carolin Loos, et al.
Published: (2023-03-01)

Therapeutic Impact of Gardasil<sup>®</sup> in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients
by: Jennifer Sieg, et al.
Published: (2025-02-01)

Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike
by: Wonyeong Jung, et al.
Published: (2024-01-01)

Fc-effector functional antibody assays for SARS-CoV-2 variants of concern
by: Xuemin Chen, et al.
Published: (2025-05-01)

Structure and Dynamics of a Site-Specific Labeled Fc Fragment with Altered Effector Functions
by: D. Travis Gallagher, et al.
Published: (2019-10-01)

394 Inclusion of cytomegalovirus viral Fc gamma receptors in a glycoprotein B protein subunit vaccine improves Fc-mediated effector responses
by: Claire Otero, et al.
Published: (2025-04-01)

Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16+ NK cell activation
by: H.A. Daniel Lagassé, et al.
Published: (2024-04-01)

Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques
by: William D. Tolbert, et al.
Published: (2022-09-01)

Combinatorial Fc modifications for complementary antibody functionality
by: Yannic C. Bartsch, et al.
Published: (2025-12-01)

Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
by: Robert Pejchal, et al.
Published: (2023-08-01)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
by: Andréa Cottignies-Calamarte, et al.
Published: (2023-02-01)

PREVALENSI DAN KARAKTERISTIK PELAYANAN VAKSINASI CERVARIX SEBAGAI PREVENSI PRIMER KANKER SERVIKS DI SMP NEGERI 1 DENPASAR PERIODE OKTOBER 2011 - APRIL 2012
by: Hendrikus Gede Surya Adhi Putra, et al.
Published: (2015-07-01)

T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNFα.
by: Yijun Shen, et al.
Published: (2017-01-01)